Pathogenetic mechanisms of ischemic stroke: from verification to secondary prevention
Ischemic stroke is an extremely heterogeneous disease: there are more than 200 causes of cerebral catastrophe. Early identification of the pathogenetic mechanism (subtype) of ischemic stroke allows planning an individual secondary prevention strategy, which includes a wide range of pharmaceutical an...
Main Authors: | Aleksey A. Kulesh, Dmitrii A. Demin, Oleg I. Vinogradov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ZAO "Consilium Medicum"
2021-11-01
|
Series: | Consilium Medicum |
Subjects: | |
Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/96604/70873 |
Similar Items
-
ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE
by: A. V. Fonyakin, et al.
Published: (2009-12-01) -
Antyhypertensive therapy-based secondary prevention of ischemic stroke
by: Vladimir Anatolyevich Parfenov, et al.
Published: (2012-03-01) -
THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
by: P. R. Kamchatnov, et al.
Published: (2014-07-01) -
THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
by: P. R. Kamchatnov, et al.
Published: (2014-07-01) -
Antiplatelets in secondary stroke prevention
by: Olga eShulga, et al.
Published: (2011-07-01)